GENE ONLINE|News &
Opinion
Blog

2026-02-05|

Calix CEO Michael Weening to Highlight Agentic AI for Personalized Subscriber Experiences at MWC 2026

by GOAI
Share To

Calix CEO Michael Weening is scheduled to deliver a keynote address at Mobile World Congress (MWC) 2026 in Barcelona. The presentation will focus on the role of agentic artificial intelligence (AI) in creating personalized subscriber experiences, referred to as an “Experience of One.” The event will take place from February 29 to March 4, 2026, and is expected to attract global leaders in technology and telecommunications.

Weening’s keynote will explore how advancements in AI technology can enable service providers to tailor their offerings for individual subscribers. He plans to discuss the concept of agentic AI, which emphasizes autonomous decision-making capabilities within AI systems. According to the announcement, this approach aims to enhance customer satisfaction by delivering highly customized services based on user preferences and behaviors. MWC Barcelona serves as a prominent platform for industry professionals to share insights on emerging technologies and trends shaping the future of connectivity.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: The formatted date is: February 5, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Ambarella to Present The Ambarella Edge Initiative on Physical AI at Embedded World 2026
2026-02-09
GXO Logistics to Manage Operations at BMW Group’s Swindon Site
2026-02-09
Trip.com Group Limited to Release Q4 and Full-Year 2025 Financial Results on February 25, 2026
2026-02-09
FireFox Gold Reports 54.91 g/t Gold Over 1.95 Meters in Northeast Zone Expansion at Mustajärvi Project
2026-02-09
TotalEnergies to Supply Google with 1 GW of Solar Energy for Texas Data Centers Over 15 Years
2026-02-09
TrumpRx Enters Pharmaceutical Market as Novo Nordisk Plans Super Bowl Ad for Oral Wegovy
2026-02-09
VHH Antibodies Derived from Camelids Show Potential for Targeted Therapies Despite Stability Challenges
2026-02-09
EVENT
2026-02-09
World Health Expo Dubai
Dubai Exhibition Centre, Dubai
2026-02-17
BIO Asia 2026 (Life Science Partnerships)
Hyderabad, India
2026-02-24
Rare Disease Week on Capitol Hill (Policy and Advocacy)
Capitol Hill, Washington, D.C.
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
2026-03-23
DCAT Week
New York, USA
Scroll to Top